Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients

This study has been completed.
Sponsor:
Information provided by:
Nestlé
ClinicalTrials.gov Identifier:
NCT00560729
First received: November 6, 2007
Last updated: November 19, 2007
Last verified: November 2007

November 6, 2007
November 19, 2007
October 2003
Not Provided
Nutritional Risk Index [ Time Frame: At J0, J21, J42 ]
Same as current
Complete list of historical versions of study NCT00560729 on ClinicalTrials.gov Archive Site
  • Measure of body mass index (BMI), Mini Nutritional Assessment, Fat mass,lean mass, serum albumin and transthyretin,Activities of Daily Living (ADL), ingesta and morbidity.
  • Tolerance [ Time Frame: Daily ]
Same as current
Not Provided
Not Provided
 
Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients
Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients

Evaluation of the effectivness and the costs of a quantitaive and qualitative nutritional supplementation in elderly patients

Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Denutrition
  • Dietary Supplement: Renutryl 500
  • Dietary Supplement: Generique
  • Dietary Supplement: Generique + Renutryl 500
  • No Intervention: I
  • Active Comparator: II
    oral nutrition
    Intervention: Dietary Supplement: Renutryl 500
  • Experimental: III
    oral nutrition
    Intervention: Dietary Supplement: Generique
  • Experimental: IV
    oral nutrition
    Intervention: Dietary Supplement: Generique + Renutryl 500
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
63
July 2007
Not Provided

Inclusion Criteria:

  • Hospitalization into a geriatric care unit
  • age > 70 years
  • C reactiv protein > 30 mg/l
  • 25 < albumin < 35 g/l
  • 130 < Na < 145 mmol/l
  • BMI < 22
  • weight loss > 10 % within the last 6 months
  • MNA < 23.5

Exclusion Criteria:

  • diabetes mellitus
  • severe digestive failure
  • enteral or parenteral nutrition
  • renal,cardiac or digestive failure
  • lactose intolerance
  • terminal phase severe pathology
  • MMS < 15
Both
70 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00560729
NCNF 0402
No
Not Provided
Nestlé
Not Provided
Study Director: Christian Aussel, PhD University PARIS V
Nestlé
November 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP